Select Page

All News

MeCRU Research Unit Officially launched as Paediatric COVID-19 VACCINE Trial Site

MeCRU Research Unit (MeCRU), at SMU has been officially launched as the research site for Phase III Paediatric COVID-19 Vaccine study conducted by the Numolux Group and Sinovac on 10 September 2021. The very first child and the second one had the honor to receive their jabs which kick started the study.

Related News

SMU nuclear medicine specialist wins health leadership award

SMU nuclear medicine specialist wins health leadership award

Dr Phumudzo Brigett Nemutaduni, a specialist nuclear medicine physician at Sefako Makgatho Health Sciences University (SMU) and Dr George Mukhari Academic Hospital (DGMAH), has received a Health Leadership Award at the Business Side of Medicine (BSOM) Gala Luncheon...

SMU academic joins prestigious national young scientists academy

SMU academic joins prestigious national young scientists academy

Sefako Makgatho Health Sciences University (SMU) is strengthening its presence in South Africa's scientific community following the selection of Dr Clarissa Marcelle Naidoo, Senior Lecturer in the Department of Biology and Environmental Sciences, as a member of the...

SMU researcher bridges traditional medicine and scientific evidence

SMU researcher bridges traditional medicine and scientific evidence

Sefako Makgatho Health Sciences University (SMU) researcher and lecturer Dr Sithembiso Lethukuthula Ndwandwe has completed a PhD in Biochemistry, advancing research into the potential of selected medicinal plants traditionally used to treat respiratory viral...